Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651573 · ClinicalTrials.gov registry record · NA
Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 722
- Enrollment target
NCT00651573 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 722 participants.
The verdict
NCT00651573, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 722 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine the best blood level to begin transfusing red blood cells in individuals undergoing cardiac surgery. The secondary aim is to determine the impact of red cell transfusion on health-related quality of life following surgery.
Interventions
- PROCEDURE Blood transfusion at hematocrit value less than 24%
- PROCEDURE Blood transfusion at hematocrit value less than 28%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 722 participants |
| Start Date | 2007-03 |
| Est. Completion | 2019-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00651573
The ClinicalTrials.gov registry entry for NCT00651573 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 722 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood transfusion at hematocrit value less than 24% is the first listed.
NCT00651573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00651573 about?
NCT00651573 is a clinical study titled "Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery". The primary purpose of this study is to determine the best blood level to begin transfusing red blood cells in individuals undergoing cardiac surgery. The secondary aim is to determine the impact of red cell transfusion on health-related quality of life following surgery.
What is the current status of trial NCT00651573?
This trial is currently completed. It is a NA study. The enrollment target is 722 participants. The study started on 2007-03. Estimated completion is 2019-01-03.
What interventions are being tested in trial NCT00651573?
The interventions under investigation include: Blood transfusion at hematocrit value less than 24% (PROCEDURE), Blood transfusion at hematocrit value less than 28% (PROCEDURE).
Who is sponsoring clinical trial NCT00651573?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.